Heart in Diabetes (HiD)
L

The Different Etiologies of Cardiomyopathy

By Heart in Diabetes (HiD) FEATURING Lee Goldberg
By Heart in Diabetes (HiD) FEATURING Lee Goldberg
12 views
October 7, 2024
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
22:42
Heart in Diabetes (HiD)

Functional Hypothalamic Amenorrhea: Consequences Beyond the Menstrua…

Feat. C. Shufelt
18:39
Heart in Diabetes (HiD)

Cardiovascular Disease in the Very Old

Feat. C. Ballantyne
09:00
Cecilia Bahit

The Best of AHA23 for the Primary Care Doctor

10:26
Transformative Endovascular Decisions Conference

New Generation of Stents Are Needed for Renal Vein Stenting

Feat. M. Razavi
10:41
ESC 2024 Insights

ESC 2024 Insights: Major Adverse Cardiovascular Events, New Diagnose…

Feat. M. Böttcher
72:22
University of Louisville

Peripheral Artery Disease: It Takes All of Us!

Feat. N. L. Lohr
14:44
FACET

MI With No Obstructive Disease: Is That a Thing

Feat. H. Hashim
21:57
Canadian Collaborative Research Network

What Every GP Should Know About Heart Failure in 2024?

Feat. S. Poon
35:05
Michigan Medicine

Updates in Heart Failure with Preserved Ejection Fraction

Feat. S. Hummel
31:27
Duke Health

Updates in Endocarditis

Feat. Z. Hager
19:56
Northwestern Medicine Endocrinology

The Connection Between Diabetes and Heart Disease

Feat. S. Shah, R. F. Kushner
41:17
Michigan Medicine

How to Evaluate and Manage HFrEF Beyond GDMT Medications

Feat. S. Hummel
22:13
Heart in Diabetes (HiD)

The Contemporary Management of Heart Failure

Feat. A. S. Desai
37:49
University of Louisville

Metabolic Mechanisms of Myocardial Hyperemia and Implications for Ex…

Feat. B. G. Hill
13:11
The North American Thrombosis Forum (NATF)

Exercise After a Cardiovascular Event

Feat. H. Skali
20:26
Heart in Diabetes (HiD)

New Emerging Treatment for DKD

Feat. C. Mende
10:14
ESC 2024 Insights

ESC 2024 Insights: Sacubitril/Valsartan Compared to Valsartan in Reg…

Feat. C. Chin
18:57
Sara D Brouse

SGLT Inhibitors in Heart Failure

21:18
Heart in Diabetes (HiD)

The Dynamic Duo: GLP-1 Receptor Agonists and SGLT2 Inhibitors

Feat. R. S. Busch
31:37
MUSC Cardiology

Weight Management for CVD and Heart Failure

Feat. S. Litwin